63064-31-3

Basic information

• Product Name: Toluene-4-sulfonic acid 2-cyclopropyl-ethyl ester
• Synonyms: Toluene-4-sulfonic acid 2-cyclopropyl-ethyl ester;2-Cyclopropylethyl 4-methylbenzenesulfonate;Toluene-4-Sulfonic Acid 2-Cyclopropyl-Ethyl Ester(WX682936)
• CAS NO: 63064-31-3
• Molecular Formula: C₁₂H₁₆O₃S
• Molecular Weight: 240.31864
• Mol File: 63064-31-3.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Toluene-4-sulfonic acid 2-cyclopropyl-ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Toluene-4-sulfonic acid 2-cyclopropyl-ethyl ester(63064-31-3)
• EPA Substance Registry System: Toluene-4-sulfonic acid 2-cyclopropyl-ethyl ester(63064-31-3)

Safety Data

• Hazardous Substances Data: 63064-31-3(Hazardous Substances Data)

Usage

General Description

Toluene-4-sulfonic acid 2-cyclopropyl-ethyl ester is a chemical compound that serves as a high-quality intermediate in the production of pharmaceutical and agrochemical compounds. It is commonly used as a reagent in organic synthesis reactions to introduce the tosyl group, and as a protecting group for alcohols in organic chemistry. This chemical has a range of applications in the fields of medicine, agriculture and industrial processes due to its unique chemical properties and reactivity. However, it is important to handle toluene-4-sulfonic acid 2-cyclopropyl-ethyl ester with caution, as it can be hazardous if not used properly.

Upstream product

• 2566-44-1 1-cyclopropylethanol 
• 98-59-9 p-toluenesulfonyl chloride 
• 104-15-4 toluene-4-sulfonic acid 

Downstream Products

• 62781-99-1 cyclopentyl formate 
• 116773-99-0 formate ester of 4-penten-2-ol 
• 1105690-47-8 N-benzyl-5-(4-(2-cyclopropylethoxy)-2-oxopyridin-1(2H)-yl)-3-methylthiophene-2-carboxamide 
• 5648-88-4 3-cyclopropylpropan-1-amine 
• 1275599-82-0 C₃₀H₃₅N₃O₆ 

Relevant articles and documents

Pyridopyril compound and medical application thereof

The invention relates to a pyridine ring compound and a medical application thereof as shown in a formula (I). The invention further relates to a preparation method of the compound. Use of a pharmaceutical composition and as FGFR4 inhibitor for the treatment of cancer.

Containing piperazinone quinazoline ketone PARP - 1/2 inhibitor and its preparation method, pharmaceutical composition and use thereof (by machine translation)

The invention discloses a new class of containing piperazinone quinazoline - 2, 4 (1 H, 3 H) - dione PARP - 1/2 inhibitor, and its preparation and pharmaceutical composition and use. Specifically, the invention relates to the general formula I shown containing of the piperazinone quinazoline - 2, 4 (1 H, 3 H) - dione derivatives and their pharmaceutically acceptable salt, and its preparation method, comprising one or more of the compounds of the composition, and the compounds in the preparation, the prevention and/or treatment with PARP - 1/2 of a disease associated with the use of the medicament. (by machine translation)

Piperazine derivatives and their use as therapeutic agents

Compounds for treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the compounds are of formula (I): where x y, W, V, R 2 , R 3 , R 4 , R 5 , R 6 , R 6a , R 7 , R 7a , R 8 , R 8a , R 9 and R 9a are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.